- 1.
European Medicines Agency, Committee for Medicinal Products for Human Use (CHMP), Summary of positive opinion: www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/003986/smops/Positive/human_smop_000886. jsp&mid=WC0b01ac058001d127 (26.10.2015)
- 2.
European Medicines Agency, Committee for Medicinal Products for Human Use (CHMP), Summary of positive opinion: www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004062/smops/Positive/human_smop_000874. jsp&mid=WC0b01ac058001d127 (26.10.2015)
- 3.
McMurray JJV, Packer M, Desai AS et al. Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure. N Engl J Med 2014; 371: 993 – 1004 DOI: 10.1056/NEJMoa1409077
()
Denne artikkelen ble publisert for mer enn 12 måneder siden, og vi har derfor stengt for nye kommentarer.